Ne-Osteo Bone Growth Factor for Posterolateral Lumbar Spine Fusion: Results from a Nonhuman Primate Study and a Prospective Human Clinical Pilot Study

Spine

Volumn 29, Issue 5, 2004, Pages 504-514

  Boden, Scott D ^a   Grob, Dieter ^b   Damien, Christopher ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Bone graft substitute; Bone morphogenetic protein; Human clinical trial; Osteoinduction; Rhesus monkeys; Spine fusion

Indexed keywords

GROWTH FACTOR; NE OSTEO; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL EXPERIMENT; ARTHRODESIS; ARTICLE; BONE MATRIX; CANCELLOUS BONE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LUMBAR SPINE; MALE; NONHUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RHESUS MONKEY; SPINE FUSION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE SCREWS; BONE TRANSPLANTATION; COMBINED MODALITY THERAPY; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUMBAR VERTEBRAE; MACACA MULATTA; MALE; OSTEOGENESIS; PATIENT SATISFACTION; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RABBITS; SINGLE-BLIND METHOD; SPINAL FUSION; SPINAL STENOSIS; SPONDYLOLISTHESIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 1442311742     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.BRS.0000101446.26071.EB     Document Type: Article

References (46)

1. Arrington ED, Smith WJ, Chambers HG, et al. Complications of iliac crest bone graft harvesting. Clin Orthop 1996;329:300-309.
2. Goulet JA, Senunas LE, DeSilva GL, et al. Autogenous iliac crest bone graft. Clin Orthop 1997;339:76-81.
3. Banwart JC, Asher MA, Hassanein RS. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine 1995;20:1055-1060.
4. Boden SD, Schimandle JH. Biologic enhancement of spinal fusion. Spine 1995;20:113.
5. Boden SD. Bioactive factors for bone tissue engineering. Clin Orthop 1999; S84-S94.
6. Urist MR, Strates, BS Bone morphogenetic protein. J Dent Res 1971;50:1392-1406.
7. Wozney JM. Bone morphogenetic proteins and their gene expression. In: Noda M, ed. Cellular and molecular biology of bone. Boston: Academic Press; 1993:131-167.
8. Urist MR. Bone. Formation by autoinduction. Science 1965;150:893-899.
9. Urist MR, Jurist Jr JM, Dubuc FL, et al. Quantitation of new bone formation in intramuscular implants of bone matrix in rabbits. Clin Orthop 1970;68:279-293.
10. Urist MR, Strates BS. Bone formation in implants of partially and wholly demineralized bone matrix. Including observations on acetone-fixed intra and extracellular proteins. Clin Orthop 1970;71:271-278.
11. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: Molecular clones and activities. Science 1988;242:1528-1534.
12. Wang EA, Rosen V, Cordes P, et al. Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci 1988;85:9484-9488.
13. Rosen V, Wozney JM, Wang EA, et al. Purification and molecular cloning of a novel group of BMPs and localization of BMP mRNA in developing bone. Conn Tiss Res 1989;20:313-319.
14. Sampath TK, Coughlin JE, Whetstone RM, et al. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-b superfamily. J Biol Chem 1990;265:13198-13205.
15. Boden SD. Clinical application of the BMPs. J. Bone Joint Surg. Am. 2001;83-A Suppl 1:S161.
16. Jeppsson C, Saveland H, Rydholm U, et al. OP-1 for cervical spine fusion: bridging bone in only 1 of 4 rheumatoid patients but prednisolone did not inhibit bone induction in rats. Acta Orthop Scand 1999;70:559-563.
17. Laursen M, Hoy K, Hansen ES, et al. Recombinant bone morphogenetic protein-7 as an intracorporal bone growth stimulator in unstable thoracolumbar burst fractures in humans: preliminary results. Eur Spine J 1999;8:485-490.
18. Cook S. Preclinical and clinicla evaluation of osteogenic protein-1 (BMP-7) in bony sites. Orthopaedics 1999;22:669-671.
19. Cunningham B, Kanayama M, Parker L, et al. Osteogenic protein versus autologous interbody arthrodesis in the sheep thoracic spine. A comparative endoscopic study using the Bagby and Kuslich interbody fusion device. Spine 1999;24:509-518.
20. Magin MN, Delling G. Improved lumbar vertebral interbody fusion using rhOP-1: a comparison of autogenous bone graft, bovine hydroxylapatite (Bio-Oss), and BMP-7 (rhOP-1) in sheep. Spine 2001;26:469-478.
21. Grauer JN, Patel TC, Erulkar JS, et al. 2000 Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion. Spine 2001;26:127-133.
22. Boden SD, Moskovitz PA, Morone MA, et al. Video-assisted lateral intertransverse process arthrodesis - Validation of a new minimally invasive lumbar spinal fusion technique in the rabbit and nonhuman primate (rhesus) models. Spine 1996;21:2689-2697.
23. Holliger EH, Trawick RH, Boden SD, et al. Morphology of the lumbar intertransverse process fusion mass in the rabbit model: A comparison between two bone graft materials - rhBMP-2 and autograft. J Spinal Disord 1996;9:125-128.
24. Martin GJ, Boden SD, Titus L. Recombinant human bone morphogenetic protein-2 reverses the inhibitory effect of ketorolac, a non-steroidal antiinflammatory drug (NSAID) on posterolateral lumbar intertransverse process spine fusion. Spine 1999;24:2188-2194.
25. Schimandle JH, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 (rhBMP-2). Spine 1995;20:1326-1337.
26. Boden SD, Schimandle JH, Hutton WC. Volvo Award in Basic Sciences. The use of an osteoinductive growth factor for lumbar spinal fusion. Part II: Study of dose, carrier, and species. Spine 1995;20:2633-2644.
27. Boden SD, Schimandle JH, Hutton WC, et al. In vivo evaluation of a resorbable osteoinductive composite as a graft substitute for lumbar spinal fusion. J Spinal Disord 1997;10:1-11.
28. Boden SD, Schimandle JH, Hutton WC. Lumbar intertransverse process spine arthrodesis using a bovine-derived osteoinductive bone protein. J Bone Joint Surg 1995;77-A:1404-1417.
29. Boden SD, Martin GJ, Morone MA, et al. The use of coralline hydroxyapatien with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion. Spine 1999;24:320-327.
30. Silcox DH, Boden SD, Schimandle JH, et al. Reversing the inhibitory effect of nicotine on spinal fusion using an osteoinductive protein extract. Spine 1998;23:291-297.
31. Martin GJ, Boden SD, Morone MA, et al. Posterolateral intertransverse process spinal fusion arthrodesis with rhBMP-2 in a non-human primate-Important lessons learned regarding dose, carrier, and safety. J Spinal Disord 1999;12:179-186.
32. Boden SD, Zdeblick TA, Sandhu HS, et al. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: A preliminary report. Spine 2000;25:376-381.
33. Huffer WE, Lewis M, Barnes T, et al. Strategies for tailoring bone and connective tissue regeneration using bone protein. In: Davies JE, ed. Bone Engineering. Toronto: EM Squared; 2000:408-420.
34. Damien CJ, Grob D, Boden SD, et al. Purified Bovine BMP Extract and Collagen for Spine Arthrodesis: Preclinical Safety and Efficacy. Spine 2002;27:S50-S58.
35. Boden SD, Schimandle JH, Hutton WC. Evaluation of a bovine-derived osteoinductive bone protein in a non-human primate model of lumbar spinal fusion. Trans Orthop Res Soc 1996;21:118.
36. Herkowitz HN, Kurz LT. Degenerative lumbar spondylolisthesis with spinal stenosis. A prospective study comparing decompression with decompression and intertransverse process arthrodesis. J Bone Joint Surg Am 1991;73:802-808.
37. Thomsen K, Christensen FB, Eiskjaer SP, et al. The effect of pedicle screw instrumentation on functional outcome and fusion rates in posterolateral lumbar spinal fusion: A prospective, randomized clinical study. Spine 1997;22:2813-2822.
38. Fischgrund JS, Mackay M, Herkowitz HN, et al. Volvo Award winner in clinical studies. Degenerative lumbar spondylolisthesis with spinal stenosis: a prospective, randomized study comparing decompressive laminectomy and arthrodesis with and without spinal instrumentation. Spine 1997;22:2807-2812.
39. McGuire RA, Amundson GM. The use of primary internal fixation in spondylolisthesis. Spine 1993;18:1662-1672.
40. Bridwell KH, Sedgewick TA, O'Brien MF, et al. The role of fusion and instrumentation in the treatment of degenerative spondylolisthesis with spinal stenosis. J Spinal Disord 1993;6:461-472.
41. Carragee EJ. Single-level posterolateral arthrodesis, with or without posterior decompression, for the treatment of isthmic spondylolisthesis in adults. A prospective, randomized study. J Bone Joint Surg. Am 1997;79:1175-1180.
42. Nork SE, Hu SS, Workman KL, et al. Patient outcomes after decompression and instrumented posterior spinal fusion for degenerative spondylolisthesis. Spine 1999;24:561-569.
43. France JC, Yaszemski MJ, Lauerman WC, et al. A randomized prospective study of posterolateral lumbar fusion. Outcomes with and without pedicle screw instrumentation. Spine 1999;24:553-560.
44. Booth KC, Bridwell KH, Eisenberg BA, et al. Minimum 5-year results of degenerative spondylolisthesis treated with decompression and instrumented posterior fusion. Spine 1999;24:1721-1727.
45. Kimura I, Shingu H, Murata M, et al. Lumbar posterolateral fusion alone or with transpedicular instrumentation in L4-L5 degenerative spondylolisthesis. J Spinal Disord 2001;14:301-310.
46. Silcox DH, Daftari T, Boden SD, et al. The effect of nicotine on spinal fusion. Spine 1995;20:1549-1553.